# LAMICTAL XR
> **NDA022115** · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2009-05-29
## Drug
- **FDA Application Number:** NDA022115
- **Application type:** New Drug Application
- **Brand name:** LAMICTAL XR
- **Generic name:** LAMOTRIGINE
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE LLC
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2009-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022115)
---
*MORVS · CC0 1.0*